AI-generated summary
This review examines long-term and preventative treatments for seasonal affective disorder, a recurrent winter depression. The authors report that light therapy usually needs daily continuation through winter because relapse is rapid when it stops early, and that bupropion XL reduced depressive recurrence in three large placebo-controlled studies. They note few studies of longer or preventative treatment, so the evidence base is limited.
- Who or what was studied
- Patients with seasonal affective disorder (SAD)
- Limits stated in the abstract
- The abstract states that few studies of longer-term and preventative treatment exist and that light therapy studies have methodological limitations.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Bright light therapy, Placebo-controlled. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.